Carcinoma, Renal Cell: all 1,992 studies
Page 9 of 20. Open to participants first (387), then studies with results posted, then the rest; newest registration first within each.
- Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell CarcinomaCompletedNCT00113217Phase 2Results posted
- CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00112840Phase 1/2Results posted
- PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney CancerTerminatedNCT00090870Phase 2Results posted
- Vaccine Treatment of Kidney CancerTerminatedNCT00089778Phase 2Results posted
- SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell CarcinomaCompletedNCT00089648Phase 2Results posted
- Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney CancerTerminatedNCT00089102Phase 2Results posted
- 17AAG to Treat Kidney Tumors in Von Hippel-Lindau DiseaseCompletedNCT00088374Phase 2Results posted
- Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney CancerCompletedNCT00087022Phase 3Results posted
- SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell CarcinomaCompletedNCT00083889Phase 3Results posted
- A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.CompletedNCT00077974Phase 2Results posted
- Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell CancerCompletedNCT00073307Phase 3Results posted
- Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell CarcinomaCompletedNCT00068393Phase 2Results posted
- Study Evaluating Interferon And CCI-779 In Advanced Renal Cell CarcinomaCompletedNCT00065468Phase 3Results posted
- Erlotinib in Treating Patients With Advanced Kidney CancerCompletedNCT00045487Phase 2Results posted
- BMS 247550 to Treat Kidney CancerCompletedNCT00030992Phase 2Results posted
- Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney CancerCompletedNCT00003656Phase 2Results posted
- Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney CancerCompletedNCT00003102Phase 1/2Results posted
- Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell CarcinomaTerminatedNCT00001703Phase 2Results posted
- First-Line Systemic Therapies in Advanced Renal Cell Carcinoma in SpainActive, not recruitingNCT07852884
- Pretreatment 18F-FDG PET/CT Radiomics for Predicting Response to First-Line Targeted Therapy Plus Immunotherapy in Metastatic Renal Cell CarcinomaCompletedNCT07827482
- Multimodal Prediction of Postoperative Prognosis After Partial Nephrectomy for Endophytic Renal Cell CarcinomaActive, not recruitingNCT07697417
- Circulating and Urinary Exosomal miRNA as Predictors of Treatment Response in Advanced Kidney CancerCompletedNCT07436416Not applicable
- Circulating and Urinary Exosomal miRNA in Advanced Kidney Cancer (EXO-RENAL1)CompletedNCT07406646Not applicable
- Predicting HIF-2α Levels in Clear Cell Kidney Cancer Using Machine LearningActive, not recruitingNCT07332923
- A Novel Haemostatic Agent for Robotic Partial NephrectomyWithdrawnNCT07284953Not applicable
- Evaluation of Hemostatic Agents in Partial NephrectomyCompletedNCT07232927Not applicable
- RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on ImmunotherapyWithdrawnNCT07218692Phase 2
- CT-based Radiomics for Prediction of MIT Family Translocation Kidney Cancer: a Multicenter, Retrospective Clinical StudyCompletedNCT07181954
- CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid TumorsSuspendedNCT07181720Phase 1
- A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid TumorsActive, not recruitingNCT07160335Phase 1
- Computed Tomography Radiomics-Derived Nomogram for Predicting Early Renal Function Decline After Partial Nephrectomy in Renal Cell Carcinoma: A Multicenter Development/Validation StudyCompletedNCT07117786
- Retrospective Study on the Safety of Nivolumab in Patients With mRCC and Renal FailureTerminatedNCT07117409
- Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCCWithdrawnNCT07084909Phase 2/3
- A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.Active, not recruitingNCT07060248
- Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell CarcinomaActive, not recruitingNCT07047001Phase 2
- Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCCCompletedNCT07024680
- Study of Lenvatinib Plus Pembrolizumab in IO Refractory mRCC Patients With Brain MetastasesWithdrawnNCT07011849Phase 2
- Symptomatic and Incidental RCC DetectionCompletedNCT07004426
- A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCCActive, not recruitingNCT07000149Phase 1
- 177LuPSMA in Renal Cell CarcinomaActive, not recruitingNCT06964958Phase 2
- Serological Autoantibodies in Early Kidney Cancer Diagnosis and Prognosis: A Multicenter StudyActive, not recruitingNCT06917560
- A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)CompletedNCT06894771Phase 1
- Nivolumab Plus Metformin in Metastatic Renal Cell CarcinomaTerminatedNCT06884683Phase 2
- Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort StudyCompletedNCT06883565
- The CT-based Deep Learning Model Predicts Complications in Partial NephrectomyCompletedNCT06876584
- Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCCSuspendedNCT06860386Phase 2
- A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoCAIX in Patients With CAIX-positive CancerCompletedNCT06840548Phase 1
- Percutaneous Tumor Ablation Vs Partial Nephrectomy for Small Renal Mass: the Impact of Histologic Variant and Tumor SizeCompletedNCT06829888
- Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCTTerminatedNCT06818305Phase 2
- Visceral Fat Area as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Multicenter Study on Postoperative SurvivalCompletedNCT06791863
- Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab DeviceCompletedNCT06789224Not applicable
- Evaluation of HPGD and SCLO2A1 Expression in Clear Cell Renal Cell Carcinoma PatientsCompletedNCT06778538
- Prognostic Significance of the Lung Immune Prognostic Index (LIPI) in Postoperative Clear Cell Renal Cell Carcinoma: a Multicenter Retrospective Cohort StudyCompletedNCT06775574
- Prehabilitation Prior to Surgery for Kidney TumorsActive, not recruitingNCT06745609Not applicable
- ClAmpless, Sutureless PartIAl Nephrectomy for Renal MassesSuspendedNCT06722807Not applicable
- A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell CarcinomaTerminatedNCT06716853Phase 1/2
- A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)Active, not recruitingNCT06708949Phase 2
- KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical StudyWithdrawnNCT06708936Early Phase 1
- A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell CarcinomaCompletedNCT06656039
- 68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCCSuspendedNCT06649682Phase 1
- Safety and Preliminary Efficacy of Meldonium in Patients with Metastatic Renal Cell Carcinoma and Treatment-associated FatigueCompletedNCT06648902Phase 1/2
- A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint InhibitorsActive, not recruitingNCT06630429
- A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid TumorsTerminatedNCT06630247Phase 1
- STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaWithdrawnNCT06626256Phase 1
- Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCCCompletedNCT06607809
- Time Restricted Eating (TRE) in Metastatic Head and Neck Squamous Cell Cancer (mHNSCC) or Unresectable or Metastatic Renal Cell Carcinoma (RCC)WithdrawnNCT06603155Not applicable
- Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal CellsSuspendedNCT06586658Early Phase 1
- A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With CancerTerminatedNCT06580938Phase 1
- A CT-BASED Deep Learning Model for Predicting WHO/ISUP Pathological Grades of Clear Cell Renal Cell Carcinoma (ccRCC) :A Multicenter Cohort StudyCompletedNCT06559046
- A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.TerminatedNCT06546553Phase 1
- Impact of Perioperative Anesthetic Management on Renal Cancer Progression.WithdrawnNCT06536244
- Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer PatientsCompletedNCT06531629
- Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the BrainActive, not recruitingNCT06500455Phase 3
- A Phase 1/2 Trial of ADI-270 in ccRCCActive, not recruitingNCT06480565Phase 1/2
- Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With CancerTerminatedNCT06456411Not applicable
- Evaluation of a Simple-Prep Controlled EmbolicActive, not recruitingNCT06453642Not applicable
- Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney CancerSuspendedNCT06391099Not applicable
- Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in PatientsCompletedNCT06389682Phase 1/2
- Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells CancerTerminatedNCT06377722Phase 2
- Optimization of Management for Sporadic Bilateral Renal Cell CarcinomaCompletedNCT06369519
- PSMA Therapy and Immunotherapy in Kidney CancerWithdrawnNCT06361810Phase 1/2
- Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE StudyCompletedNCT06339138
- A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsTerminatedNCT06336148Phase 1
- Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial CarcinomaActive, not recruitingNCT06318871Early Phase 1
- Evaluation of the Safety of Reoperation for Ipsilateral Recurrent Tumors After Nephron-sparing Partial NephrectomyCompletedNCT06317207
- A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).Active, not recruitingNCT06307431Phase 2
- NM32-2668 in Adult Patients With Selected Advanced Solid TumorsTerminatedNCT06299163Phase 1
- A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid TumorsTerminatedNCT06285097Phase 1
- A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC)Active, not recruitingNCT06284564Phase 2
- AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)Active, not recruitingNCT06245915Phase 1/2
- Primary Care-Based Follow-up of Cancer Survivors of the Prostate and KidneyCompletedNCT06214000
- Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal CancerCompletedNCT06195150
- Study of Zanzalintinib (XL092) + AB521 and Zanzalintinib + AB521 + Nivolumab in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Other Advanced Solid Tumors (STELLAR-009)TerminatedNCT06191796Phase 1
- Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - ItalyCompletedNCT06161233Not applicable
- A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid TumorsTerminatedNCT06158958Phase 1
- A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid TumoursActive, not recruitingNCT06147037Phase 1
- Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCCCompletedNCT06138496Phase 2
- A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the BrainActive, not recruitingNCT06132945Phase 1
- Study of ST-1898 in Advanced Renal Cell CarcinomaActive, not recruitingNCT06127238Phase 1/2
- MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular MarkersActive, not recruitingNCT06126159Not applicable